Significance of lymph node sampling in epithelial carcinoma of the ovary

Gynecologic Oncology
F CarninoP F Conte

Abstract

From 1979 to 1984, 127 patients operated on for ovarian cancer underwent pelvic, para-aortic, or pelvic and para-aortic lymph node sampling. Forty-seven patients proved to be stage I(14 IA and 33 IC), 14 were stage II(3 IIA, 8 IIB, and 3 IIC), 58 were stage III (7 IIIA, 13 IIIB, and 38 IIIC), and 8 were stage IV. Positive lymph nodes were found in 4.2% of patients at stage I, 35.7% at stage II, 41.3% at stage III, and 87.5% at stage IV. With regard to grading, positive lymph nodes were found in 4.4% of G1, in 21.6% of G2, and in 49.1% of G3. A significant increase in survival (P = 0.04) was found for patients classified as stage IIIC only according to lymph node involvement compared to patients in peritoneal stage IIIC with positive lymph nodes (3-year survival: 46% vs 12%). A small increase in survival was observed for N- patients compared to N+ patients, at both stage III and IV, even with same residual tumor size, but the difference is not statistically significant. All other things being equal, because the prevalence of lymph node positivity depends closely on the number of lymph nodes removed and examined (OR = 3.9 for >10 lymph nodes removed compared to 1-5 lymph nodes removed), lymph node sampling does not seem to be a r...Continue Reading

References

Mar 1, 1989·Baillière's Clinical Obstetrics and Gynaecology·P C WuL J Lian
May 1, 1989·Obstetrics and Gynecology·H S Amdur, R E Levin
Feb 1, 1994·American Journal of Obstetrics and Gynecology·E PetruR Winter

❮ Previous
Next ❯

Citations

Feb 25, 2000·The Australian & New Zealand Journal of Obstetrics & Gynaecology·D G Allen, J Coulter
Jan 20, 2004·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Paula J WoodwardJeff S Saenger
Feb 19, 2013·Trials·Marjolein KleppeRoy F P M Kruitwagen
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F. Di Re, G. Baiocchi
Jun 13, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·S TangjitgamolN Kaewpila
Apr 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P HarterA du Bois
Jan 8, 2015·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Robert BachmannCornelia Bachmann
Dec 1, 2008·Journal de chirurgie·D Salet-Lizée, S Alsary
Oct 11, 2011·Gynecologic Oncology·M KleppeR F P M Kruitwagen
Mar 6, 2015·Journal of Cancer Research and Clinical Oncology·Cornelia BachmannEva-Maria Grischke
Feb 27, 2007·Gynecologic Oncology·Augusto PereiraPaul M Magtibay
Jun 22, 2010·BJOG : an International Journal of Obstetrics and Gynaecology·R RouzierE Daraï
Jan 18, 2011·Journal of Surgical Oncology·Haider MahdiAdnan R Munkarah
Nov 5, 2002·Best Practice & Research. Clinical Obstetrics & Gynaecology·Pierluigi Benedetti Panici, Roberto Angioli
May 10, 2016·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Ahmet PadakSeyran Yiğit
Aug 19, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marjolein KleppeRoy F P M Kruitwagen
Jul 29, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Victor LagoChristina Fotopoulou
Sep 24, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Marjolein KleppeMarco C DeRuiter
Jun 15, 2007·International Journal of Clinical Oncology·Kimio Ushijima
May 28, 2009·Journal of Gynecologic Oncology·Hee-Sug Ryu
Jun 15, 2001·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·UNKNOWN ADASP Committee. The Association of Directors of Anatomic and Surgical Pathology
Nov 23, 2011·Journal of Cancer Research and Clinical Oncology·C BachmannE F Solomayer
Jun 19, 2012·Annals of Surgical Oncology·Antonino DittoFrancesco Raspagliesi
Mar 4, 1998·Current Opinion in Obstetrics & Gynecology·L M Chen, J S Berek
Jun 23, 2001·The American Journal of Surgical Pathology·UNKNOWN Association of Directors of Anatomic and Surgical Pathology
Apr 9, 2010·Archives of Gynecology and Obstetrics·Hyuck Jae ChoiSang-Yoon Park
May 24, 2011·Current Opinion in Oncology·J Baptist Trimbos
Oct 6, 2016·Molecular and Clinical Oncology·Cornelia BachmannDiethelm Wallwiener
Mar 20, 2019·Open Medicine·Xiaoxia TongYuan Xu
Sep 3, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Federica Dell'OrtoAlessandro Buda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.